Genovior Biotech Corporation
Update:2026/01/07
Industries
Main Industry
Biotechnology
Main Product/Service
1. process development of peptide or protein APIs from microbial or human recombinant fermentation processes
2. formulation development of biological injectable
3. manufacturing capacities of biological APIs, lyophilized injectable, and prefilled syringe/
2. formulation development of biological injectable
3. manufacturing capacities of biological APIs, lyophilized injectable, and prefilled syringe/
Founded Year
2015
Unified Business No.
24890496
Status
Active
Number of Employees
165
Total Paid-in
Capital
1,545,951,330 (NT$)
Location of Company
Taiwan
, Hsinchu County
Exit Status
Acquired(2025)
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Genovior is a dedicated CDMO focus on process development, scale up, formulation development, and productivity optimization under PIC/S GMP (cGMP, EU GMP) for our customers worldwide. Our one-stop services conveniently provide effective and efficient solu
Corporate Video